Nandor Szegedi
Overview
Explore the profile of Nandor Szegedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szegedi N, Komlosi F, Merkely B, Geller L
Clin Res Cardiol
. 2025 Mar;
PMID: 40072567
No abstract available.
2.
Heeger C, Almorad A, Scherr D, Szegedi N, Baran J, Duytschaever M, et al.
Europace
. 2024 Nov;
PMID: 39504572
Background: Temperature-controlled high-power short-duration (HPSD) radiofrequency catheter ablation for pulmonary vein isolation (PVI) utilizing a novel ablation catheter (QDOT Micro) with real-time assessment of catheter tip temperature aims for safer,...
3.
Perge P, Petrovic N, Sallo Z, Piros K, Nagy V, Abraham P, et al.
Europace
. 2024 Oct;
26(10).
PMID: 39373571
Aims: The predictive role of local impedance (LI) drop in lesion formation using a novel contact force sensing ablation catheter was recently described. The purpose of our current study was...
4.
Amin M, Abdrakhmanov A, Kropotkin E, Traykov V, Sallo Z, Geller L, et al.
Pacing Clin Electrophysiol
. 2024 Sep;
47(11):1441-1448.
PMID: 39331462
Introduction: The reduction of fluoroscopic exposure during catheter ablation of supraventricular arrhythmias is widely adopted by experienced electrophysiology physicians with a relatively short learning curve and is becoming the standard...
5.
Boga M, Orban G, Sallo Z, Nagy K, Osztheimer I, Ferencz A, et al.
J Cardiovasc Dev Dis
. 2024 Aug;
11(8).
PMID: 39195138
Background: Recurrences due to discontinuity in ablation lines are substantial after pulmonary vein isolation (PVI) with radiofrequency ablation for atrial fibrillation. Data are scarce regarding the durability predictors for very...
6.
Toth P, Arnoth B, Komlosi F, Szegedi N, Sallo Z, Perge P, et al.
J Cardiovasc Electrophysiol
. 2024 May;
35(7):1471-1479.
PMID: 38803006
Introduction: According to current guidelines, pulmonary vein isolation as first-line therapy should be considered for patients with atrial fibrillation (AF), however, optimal timing of the procedure is still unknown in...
7.
Boga M, Orban G, Perge P, Sallo Z, Tanai E, Ferencz A, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610727
Atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI) is predominantly attributed to pulmonary vein reconnection (PVR). Predictors of AF recurrence have been widely studied; however, data are scarce on...
8.
Szegedi N, Sallo Z, Nagy V, Osztheimer I, Hizoh I, Lakatos B, et al.
Circ Arrhythm Electrophysiol
. 2024 Jan;
17(2):e012402.
PMID: 38284286
Background: High-power short-duration ablation has shown impressive efficacy and safety for pulmonary vein isolation (PVI); however, initial efficacy results with very high power short-duration ablation were discouraging. This study compared...
9.
Piros K, Vida A, Szegedi N, Perge P, Sallo Z, Ferencz A, et al.
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38255747
Background: Safety, efficacy, and patient comfort are the expectations during pulmonary vein isolation (PVI). We aimed to validate the combined advantages of pre- and periprocedural anticoagulation with non-vitamin K anticoagulants...
10.
Komlosi F, Toth P, Bohus G, Vamosi P, Tokodi M, Szegedi N, et al.
Bioengineering (Basel)
. 2023 Dec;
10(12).
PMID: 38135977
Background: Ventricular tachycardia (VT) recurrence after catheter ablation remains a concern, emphasizing the need for precise risk assessment. We aimed to use machine learning (ML) to predict 1-month and 1-year...